UBS Group’s NewGenIvf Group Warrants NIVFW Stock Holding History

UBS Group’s Portfolio NIVFW Stock Details NIVFW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$724	Buy	+31,496	New	+$627	﹤0.01%	10503
2025 Q4	–	Sell	-1,380	Closed	-$23	–	11306
2025 Q3	$23	Buy	+1,380	New	+$33	﹤0.01%	10121
2025 Q2	–	Sell	-2,683	Closed	-$48	–	10959
2025 Q1	$48	Buy	2,683 +60	+2%	+$2	﹤0.01%	10018
2024 Q4	$118	Sell	2,623 -1,069	-29%	-$33	﹤0.01%	9634
2024 Q3	$63	Buy	3,692 +3,610	+4,402%	+$117	﹤0.01%	9216
2024 Q2	$2	Buy	+82	New	+$4	﹤0.01%	9426

Other funds holding NIVFW

Mint Tower Capital Management Amsterdam, Netherlands $589M AUM 6.02% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $990M AUM 4.73% 1-Year Est. Return

UBS Group's NIVFW Position: Q3 2026 in Review

UBS Group opened a new position in NewGenIvf Group Warrants (NIVFW) in Q3 2026: 31,496 shares worth $724. The stake represents ﹤0.01% of the portfolio and ranks #10503 among its holdings. This is a return to the name: UBS Group previously reported a position in NIVFW as recently as Q3 2025.

UBS Group first reported a position in NIVFW in Q2 2024 and has held it in 6 quarters since. 3 funds tracked by Wall St. Rank hold NIVFW as of Q3 2026.

UBS Group held 31,496 shares of NewGenIvf Group Warrants worth $724 as of Q3 2026.
NewGenIvf Group Warrants was a new UBS Group position in Q3 2026.
NewGenIvf Group Warrants made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #10503 holding.
UBS Group first reported a position in NewGenIvf Group Warrants in Q2 2024 and has held it in 6 quarters since.
3 funds tracked by Wall St. Rank held NewGenIvf Group Warrants as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.